|
 |
|
Emerging Cancer Diagnostic Tests and Companies Developing New Technologies and Products
The report provides a comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects, for the major categories of both circulating and cellular tests, such as Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines, Immunohistochemical Stains and others.
The report presents an overview of the clinical significance and market needs for both current and emerging cancer diagnostic tests, as well as extensive listings of companies, universities and research centers developing or marketing new technologies, products, and applications.
Contains 260 pages and 30 tables
|
 |
|
$2850.00 |
| |
|
|
|
Blood Typing, Grouping and Infectious Disease Screening Tests: Analysis of Current and Emerging Assays and Companies Developing New Technologies and Products
The report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing new blood banking technologies and products.Contains 195 pages and 7 tables
|
|
|
$2500.00 |
| |
|
|
|
Leading Cancer Diagnostics Market Players: Strategic Assessments of Major Suppliers and Emerging Market Entrants
This report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Contains 80 pages
|
|
|
$2500.00 |
| |
|
|
|
Siemens: Performance, Capabilities, Goals and Strategies in the Worldwide Healthcare Market
A strategic assessment of Siemens, one of the world's leading healthcare companies, provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global healthcare market.Contains 111 pages and 9 tables
|
|
|
$1900.00 |
| |
|
|
|
Leading Blood Banking Market Players: Strategic Assessments of Major Suppliers and Emerging Market Entrants
This report presents extensive analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.Contains 50 pages
|
|
|
$1850.00 |
| |
|
|
|
Blood Banking Technologies: Assessment of Current and Emerging Technologies, and Their Potential Market Applications
This report provides a detailed analysis of 13 current and emerging technologies, and their potential market applications.Contains 75 pages
|
|
|
$1850.00 |
| |
|
|
|
Cancer Diagnostic Technologies: Assessment of Emerging Technologies and Market Applications
This report provides detailed assessments of such technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for cancer diagnostic testing. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy.Contains 110 pages
|
|
|
$1850.00 |
| |
|
|
|
Blood Banking: a Worldwide Market Overview - Facilities, Test Volumes, and Sales Forecasts for Typing, Grouping and Infectious Disease Screening Tests by Country
This report provides a worldwide overview of the blood banking market, including estimates of facilities performing blood banking tests, as well as test volume, reagent and instrument sales forecasts for blood typing, grouping and infectious disease screening tests by country.Contains 15 pages and 5 tables
|
|
|
$1450.00 |
| |
|
|
|
Blood Banking Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers
This report reviews current instrumentation technologies, and compares features of over 20 leading blood banking automated and semiautomated analyzers.Contains 25 pages
|
|
|
$950.00 |
| |
|
|
|
The Blood Banking Market: New Product Development Opportunities, Market Penetration Strategies, Entry Barriers and Risks
The report identifies the major opportunities for blood banking instruments, consumables, and auxiliary products proposes ideal product models with tentative prices and operating characteristics and suggests alternative market penetration strategies for suppliers. Contains 15 pages
|
|
|
$950.00 |
| |
|
|
|
Cancer Diagnostic Testing Instrumentation: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers
This report reviews current instrumentation technologies, and compares features of major automated and semiautomated analyzers used for tumor marker testing.
Contains 25 pages
|
|
|
$950.00 |
| |
|
|
|
Cancer Diagnostics Market: New Product Development Opportunities, Market Penetration Strategies, Entry Barriers and Risks
The report identifies major opportunities emerging in the cancer diagnostics market during the next ten years proposes ideal product models with tentative prices and operating characteristics and suggests alternative business expansion strategies for suppliers.Contains 15 pages
|
|
|
$850.00 |
| |
|
|
|
|